Crossref
Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: interpreting the AGICC study
Annals of Pancreatic Cancer · 2026-08 · 9 · 22-22
DOI: 10.21037/apc-26-0015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Pancreatic Cancer, 2026-08. Verfasst von Daire Hanna und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hanna, D., & Propper, D. (2026). Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: interpreting the AGICC study. Annals of Pancreatic Cancer, 9, 22-22. https://doi.org/10.21037/apc-26-0015
Vancouver
Hanna D, Propper D. Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: interpreting the AGICC study. Annals of Pancreatic Cancer. 2026;9:22-22. doi:10.21037/apc-26-0015
BibTeX
@article{Hanna2026,
author = {Hanna, Daire and Propper, David},
title = {Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: interpreting the AGICC study},
journal = {Annals of Pancreatic Cancer},
year = {2026},
volume = {9},
pages = {22--22},
doi = {10.21037/apc-26-0015}
}
EUVIMED